GNPX GENPREX INC

NASDAQ
$3.29

GENPREX INC (GNPX) is expected to report earnings on November 13, 2026, before the market open.

GENPREX INC Reported Earnings
Friday, August 14, 2026 · 12:00 AM ET
Earnings Date
Nov 13
Friday · Before Open
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About GENPREX INC

Genprex Inc. operates as a biotechnology company. It discovers and develops immunogene therapies for cancer treatment as well as clinical research, gene therapies, consulting and other related medical services. The company's initial product candidate is Oncoprex(TM) immunogene therapy which treats non-small cell lung cancer. Genprex Inc. is based in United States.

Sector

Healthcare

Charts powered in part by Lightweight Charts™ by TradingView.